Investigation Into the Safety of Intradermal Juvidex (M6P) Administered to Wounds of Healthy Subjects

计划入组 70 人 · 首次发布于 2009 年 9 月 25 日

A Phase 1 Study of LY2874455 in Participants With Advanced Cancer

计划入组 94 人 · 首次发布于 2010 年 9 月 30 日

Mineralocorticoid Receptor, NMDA Receptor and Cognitive Function in Depression

计划入组 232 人 · 首次发布于 2017 年 2 月 23 日

docitaxel (Receptor)

TrkB receptor-agonizing mAbs (Wyeth)

nuclear receptor antagonist

Arvinas Estrogen Receptor, Inc.

United States

Arvinas Androgen Receptor, Inc.

United States

Veru Inc

United States

Amicus Therapeutics Secures Japan Approval for Pombiliti + Opfolda Combination Therapy for Late-Onset Pompe Disease

CDSCO Panel Approves Label Updates for Sanofi's Rare Disease Therapies Fabrazyme and Aldurazyme

Amicus Therapeutics Reports 15% Revenue Growth in Q1 2025, Expands Portfolio with DMX-200 Licensing Deal